Introduction
============

Norepinephrine (NE) has long been implicated in fear and anxiety (Gray, [@B35]; Redmond, [@B69]; Aston-Jones and Bloom, [@B13]; Aston-Jones et al., [@B14], [@B15]; Sullivan et al., [@B79]), and is known to play a role in learning and memory (Ferry et al., [@B31]; Bailey et al., [@B16]; McGaugh, [@B56]). However, the contribution of NE to Pavlovian fear conditioning, a leading model for understanding the neural basis of fear and anxiety and learning and memory, is poorly understood. Recent studies suggest that NE contributes to the acquisition but not the consolidation of fear conditioning (Lee et al., [@B50]; Debiec and LeDoux, [@B22]; Grillon et al., [@B36]; Murchison et al., [@B60]; Bush et al., [@B20]). The lateral nucleus of the amygdala (LA) is a critical brain region for fear learning (LeDoux, [@B49], [@B48]; Rodrigues et al., [@B72]; Maren, [@B54]; Lang and Davis, [@B47]) and blocking beta-adrenergic receptors (βARs) within the LA disrupts the acquisition of fear conditioning (Bush et al., [@B20]). Previous studies have shown that the amygdala is extensively innervated by noradrenergic fibers, primarily originating from the locus coerulus (Moore and Card, [@B59]; Fallon and Ciofi, [@B25]; Asan, [@B10], [@B11]). Several studies have examined the ultrastructural relations of NE terminals in the basolateral complex or basolateral nucleus (BLA) (Asan, [@B10], [@B11]; Li et al., [@B53], [@B52]). However, the BLA contains two major subdivisions, the LA and the basal nucleus (B), each with distinct connections (Pitkänen et al., [@B65]), and the LA, but not the B, is necessary for fear conditioning (Amorapanth et al., [@B3]; Nader et al., [@B61]). Moreover, the results of these ultrastructural NE studies differed: one study showed that within the basal complex, NE terminals rarely formed synapses (Asan, [@B11]) while another showed a greater proportion of NE terminals forming synapses, including with other terminals (Li et al., [@B53]). Electrophysiological studies have shown that βARs play a role in synaptic transmission (Gean et al., [@B32]; Huang et al., [@B39], [@B42]; Ferry et al., [@B31]; Buffalari and Grace, [@B18]) and LTP (Johnson et al., [@B46]) in the amygdala. While anatomical studies have characterized the cellular and subcellular distribution of βARs in other brain regions (Aoki et al., [@B9]; Aoki, [@B4], [@B5]; Aoki and Pickel, [@B7]; Milner et al., [@B57]), little is known about the cellular and subcellular distribution of βARs within the amygdala. Using commercial antibodies directed against the β~1~ and β~2~ receptor subtypes, one confocal microscopic study found that the β~1~ and β~2~ receptor subtypes are widely distributed in basal amygdala neurons but not in astrocytes (Qu et al., [@B66]). This group also found that while both receptor subtypes were seen in the membranes and cytoplasm of cell bodies, the β~2~ receptor subtype, but not the β~1~, was localized to the nucleus. To understand better the cellular mechanisms of NE\'s contributions to fear learning, we examined the anatomical organization of NE terminals and βARs in the LA. In this study, we employed immunoelectron microscopy to determine whether terminals immunoreactive for dopamine beta-hydroxylase (DβH), the synthetic enzyme for NE, form synaptic junctions in the LA and if so, examine these synapses and identify the post-synaptic targets on NE terminals. To determine the cellular and subcellular distributions of βARs in the LA, we used previously characterized antibodies directed against two different isoforms of βARs: βAR 248, an antibody that predominately recognizes neurons, and βAR404, which primarily detects astrocytes.

Materials and Methods
=====================

Male Sprague--Dawley (Hilltop Lab Animals, Inc; Scottdale, PA, USA) rats weighing 300--400 g (*n* = 8) were used for studies. All procedures used were approved by the Animal Use and Care Committee of New York University, and conform to the guidelines of the National Institutes of Health on Care and Use of Experimental Animals in Research.

Tissue fixation
---------------

Naïve animals were anaesthetized with chloral hydrate (25%; 1--1.5 g/kg BW) and transcardially perfused with 25--30 ml of heparinized 0.9% saline followed by either: 50 ml of 3.0% acrolein mixed into 4% paraformaldehyde (PFA), followed by 450 ml of 4% PFA dissolved in 0.1 M phosphate buffer (PB, pH 7.4; *n* = 4), or 500 ml 0.1% glutaraldehyde/4% PFA (*n* = 4). The brains were removed from the skull, blocked, and post-fixed in 4% PFA for 30 min. Blocks containing the amygdala were cut on a Vibratome and 40-μm coronal sections were collected. Tissue sections were treated with 1% sodium borohydride in PB for 30 min and rinsed with phosphate-buffered saline (0.01 M PBS, pH. 7.4).

Immunocytochemical labeling
---------------------------

Following rinses in PBS, tissue sections were preincubated in PBS containing 1% (w:v) bovine serum albumin (BSA) for 30 min. The sections were incubated overnight at room temperature with either a mouse monoclonal antibody directed against DβH (1:500; Millipore, Temecula, CA, USA) or rabbit polyclonal antiserum directed against the one of the β-adrenergic receptors. The following day, the tissue was rinsed in PBS, incubated for 30 min in a solution containing a 1:200 dilution of either goat anti-mouse for DβH or goat anti-rabbit biotinylated IgG for βAR (1:200; Vector Labs, Burlingame, CA, USA), rinsed, and incubated for 30 min in ABC (Vector Labs) solution. The reaction product was then visualized by incubation in 0.022 % 3-3′-diaminobenzidine (DAB; Sigma, St. Louis, MO, USA) and 0.003% hydrogen peroxide. All primary and secondary antisera incubations included 1% BSA and diluents containing PBS. Triton-X was added to the DβH primary antibody solution (0.2% for light microscopy, 0.05% for electron microscopy). All incubations were performed at room temperature with continuous agitation. For dual-label fluorescent experiments, tissue was incubated overnight in βAR 248 as described above, rinsed, and incubated with goat anti-rabbit IgG conjugated to Alexa 594 (1:200; Invitrogen, Carlsbad, CA, USA) for 1 h. The tissue was then rinsed, preincubated in 1% BSA and incubated overnight in either antibodies made in mouse either to GABA (1:2000; ICN Biochemicals, Costa Mesa, CA, USA) or CAMKII (1:200; Upstate, Lake Placid, NY, USA). The following day, the tissue was rinsed, and incubated in goat anti-mouse conjugated to Alexa 488 (1:200). Tissue sections for light and confocal microscopy were mounted on slides coated with gelatin. Tissue sections designated for LM analysis were dehydrated in a graded series of alcohol, defatted in xylene and coverslippped with Permount (Fisher Scientific). Fluorescent tissue was mounted and coverslipped with Prolong Gold (Invitrogen). The final preparations were examined on either a Nikon FXA and photographed with a Coolsnap digital camera (Roper Scientific, Trenton, NJ, USA) or a Zeiss LSM 310 and Leica TCS SP2 confocal microscope.

Electron microscopic processing
-------------------------------

Tissue sections designated for EM were processed as previously described (Farb and LeDoux, [@B29]). In brief, tissue sections containing the amygdala were incubated in 1% osmium tetraoxide/PB, dehydrated in a graded series of alcohols, stained en bloc in uranyl acetate, further dehydrated in acetone and subsequently flat-embedded in EMbed. Portions of the tissue containing the amygdala were cut and glued (Super Glue; Rancho Cucamonga, CA, USA) onto Beem capsules and placed at 60°C for 10 min. Photographs of the amygdala were taken and ultrathin sections (85 nm) were cut from the dorsolateral division of the LA (Figure [1](#F1){ref-type="fig"}A). Ultrathin sections were collected on 8--12 nickel grids and the tissue was examined on a JEOL 1200EX electron microscope. Photographs were taken using a Hammamatsu digital camera (AMT; Danvers, MA, USA). Electron micrographs were collected from the dorsolateral amygdala of four animals with the best morphological preservation. For each brain, ultrathin sections from at least two vibratome sections containing the AL were examined. Labeled terminals were identified by the presence of peroxidase reaction product within processes and were distinguished from preterminal axons by the presence of vesicles. Immunoreactive terminals without distinct membrane boundaries or whose peroxidase reaction product was too dense to distinguish between it and the post-synaptic density were not included in the analysis. Immunoreactive terminals were characterized as either forming or not forming synaptic contacts by the presence of a post-synaptic membrane specialization, intercleft filaments, and widened (10--20 nm) parallel spacing of plasma membranes (Peters et al., [@B64]). Labeled terminals with thickened post-synaptic densities and widened synaptic clefts were classified as asymmetric while terminals with thin post-synaptic densities and narrower synaptic clefts were identified as symmetric. Appositions were characterized by close membrane associations not separated by astrocytic processes, the lack of conventional synaptic clefts, intercleft material or dense specializations. Dendritic shafts were arbitrarily characterized as large (i.e. proximal) if their diameter was greater than 0.5 μm, or small (i.e., distal) if their diameter was less than 0.5 μm. Dendritic spines were smaller than dendrites and lacked mitochondria.

![**Light micrographs showing dopamine beta-hydroxylase (DβH) and beta-adrenergic receptors (βARs) in the amygdala**. **(A)** Dark-field micrograph shows DβH in the amygdala. Trapezoid corresponds to area examined by electron microscopy. **(B)** Higher-magnification dark-field micrograph illustrates thin, varicose DβH axons. Arrowheads point to varicosities. **(C,D)** Low-magnification bright-field micrographs show βAR 248 **(C)**, and βAR 404 **(D)** are distributed homogenously throughout the amygdala. **(E)** Higher magnification shows that βAR 248 intensely labels somata and some proximal dendrites (arrowheads). The nuclei of some labeled cells are seen in some cells (arrows) but are difficult to distinguish in others. **(F)** Higher-power Nomarski optics show labeled astrocytic cell bodies (arrowheads) and their radiating processes (arrows). Also shown is an astrocytic process (asterisks) surrounding a blood vessel (BV). Scale bar = 100 μm in **A**--**D**, 50 μm in **B, E**, and **F**. BLA, basolateral amygdala; Ce, central amygdala; LA, lateral amygdala.](fnbeh-04-00162-g001){#F1}

Antibody specificity
--------------------

In this study, we used mouse monoclonal antibodies directed against DβH, CAMKII, and GABA that have been characterized in previously published reports (Li et al., [@B52]; McDonald et al., [@B55]; Balcita-Pedicino and Rinaman, [@B17]; Schiltz and Sawchenko, [@B73]; Howorth et al., [@B38]). The pattern of DβH-immunoreactivity we describe is consistent with previously published reports in the amygdala complex (Fallon et al., [@B26]; Fallon and Ciofi, [@B25]; Roder and Ciriello, [@B71]; Asan, [@B10], [@B11]; Li et al., [@B53], [@B52]). Earlier studies have shown that within the LA, DβH is a specific marker for NE and does not label the other catecholaminergic biosynthetic enzymes, phenyl-methyl transferase (PNMT), the marker for adrenergic axons, or tyrosine-hydroxylase (TH), the marker for dopaminergic axons (Fallon et al., [@B26]; Fallon and Ciofi, [@B25]; Asan, [@B10]; Roder and Ciriello, [@B71]). Specifically, these studies have shown that PNMT immunoreactivity in the LA is scarce or nearly absent while TH-ir differs markedly and is non-overlapping. We also used rabbit antisera directed against β~2~AR that was generated by using synthetic peptides corresponding to amino acids 248--256 (βAR 248) and 404--418 (βAR 404) of hamster lung β~2~ARs (Dixon et al., [@B24]). The βAR 404 antiserum recognizes both the β~1~- and β~2~-subtypes (Strader et al., [@B77],[@B78]). The antiserum to βAR 248 (1:1K) was directed against the third cytoplasmic loop while the antiserum for βAR 404 (1:1K) was directed against the C-terminus of the receptor. The specificity of βAR 404 antisera has been previously characterized using Western blot (Strader et al., [@B78]) and immunoprecipitation of radiolabeled βAR (Strader et al., [@B77]). Preadsorption controls to the synthetic peptides using the exact correspondence to the antigens that were used to generate the βAR 248 and 404 antisera were also performed (Aoki, [@B5]). Antisera against βAR 248 and βAR 404 were generously provided by Dr. C.D Strader of Merck Sharp and Dohme Research Laboratories. Immunoreactivity was absent from tissue in which the primary antisera was omitted from the incubation solutions or the secondary antibody was mismatched to the primary antibody, e.g., anti-mouse IgG instead of the anti-rabbit IgG, and the tissue was reacted as described above.

Results
=======

Light microscopy
----------------

### The LA contains a dense plexus of dopamine beta-hydroxylase fibers

The pattern of DβH-immunoreactivity (-ir) in the amygdala has been described previously (Moore and Card, [@B59]; Fallon and Ciofi, [@B25]; Asan, [@B10], [@B11]; Li et al., [@B53], [@B52]). In brief, in both glutaraldehyde and acrolein-fixed tissue, DβH fibers appeared as a dense plexus and were distributed throughout the LA (Figure [1](#F1){ref-type="fig"}A). DβH fibers were fine and varicose and coursed through the amygdala in both dorsal--ventral and medial--lateral directions (Figure [1](#F1){ref-type="fig"}B).

### Beta-adrenergic receptor immunoreactivity occurs throughout the LA

Immunoreactivity for both β~2~AR antisera was distributed throughout the LA. By light microscopy, numerous cells were labeled. (Figures [1](#F1){ref-type="fig"}C,D). βAR 248 densely labeled neuronal perikarya and the proximal portions of their dendrites. In some LA cells, the reaction product rimmed the cytoplasm and the nucleus was well delineated whereas in other cells, the reaction product obscured the nuclei (Figure [1](#F1){ref-type="fig"}E). βAR 404-ir was observed in small cell bodies that appeared astrocytic: many labeled processes radiated from small perikarya (Figure [1](#F1){ref-type="fig"}F). Some labeled processes followed the contours of blood vessels.

Confocal microscopy reveals βars are localized to both excitatory and inhibitory cells
--------------------------------------------------------------------------------------

To determine whether βAR248 was localized to specific cells types, we dually labeled tissue for βAR248 and CAMKII, a marker for excitatory, pyramidal-like cells in the LA (McDonald et al., [@B55]) and examined the tissue by confocal microscopy. We also dually labeled tissue for βAR 248 and GABA to establish whether GABAergic cells contain βARs. By confocal microscopy, βARs were localized to both LA excitatory and inhibitory cells (Figures [2](#F2){ref-type="fig"}A,B).

![**Confocal micrographs show that βAR 248 is localized to both excitatory and inhibitory LA cells**. **(A)** Cells immunopositive for CAMKII (green) are also immunoreactive for βAR 248 (red). Arrows point to dually labeled cells while the asterisk indicates a cell singly labeled for βAR 248. **(B)** GABAergic cells (green) also contain βAR 248 (red). Arrows point to cells dually labeled for βAR 248 and GABA; asterisks indicate βAR 248 singly labeled cells.](fnbeh-04-00162-g002){#F2}

Electron microscopy
-------------------

### Most DβH terminals do not form synapses within single sections

Most of our EM analysis was performed on tissue fixed with acrolein since both the ultrastructure and membrane preservation were superior to tissue fixed with low levels of glutaraldehyde. Four hundred and ten DβH-labeled terminals were analyzed from tissue taken from the four animals with the best morphology. Analysis was performed on three animals perfused with acrolein and one animal perfused with glutaraldehyde. Ultrathin sections were collected from 3--4 vibratome sections from each animal for a total of 14 samples. DβH-labeled terminals were unmyelinated and varied in size from 0.4--1.5 μm. DβH terminals contained small, clear vesicles, though many terminals also contained 1--5 dense-core vesicles (Figures [3](#F3){ref-type="fig"}A--F). DβH terminals frequently contained mitochondria and some DβH-labeled axons appeared to follow the contours of blood vessels (Figure [4](#F4){ref-type="fig"}A). Frequently, the reaction product filled the axoplasm and obscured the morphological features of the terminal. Those terminals whose membranes were not intact due to the use of detergent were not included in the analysis. The vast majority of DβH terminals did not form synapses in a single plane of section (282/410 or 69%) (Figures [3](#F3){ref-type="fig"}A,E). About half the DβH terminals (223/410, or 54%) were directly apposed to unlabeled terminals (Figures [3](#F3){ref-type="fig"}B,C,E,F). In some instances (9/410 or 2%) possible axo--axonic contacts were observed: the plasma membranes of DβH terminals showed close and parallel alignment with the plasma membrane of unlabeled terminals and some intercleft density was present (Figure [4](#F4){ref-type="fig"}A). When DβH terminals did form synapses, most formed symmetric synapses (90/128 or 70%) (Figure [5](#F5){ref-type="fig"}A) and the vast majority of these (75/90, 83%) occurred on dendrites (Figures [3](#F3){ref-type="fig"}B,D) though some symmetric synapses were made on spines (13/90, 14%) and two occurred on somata (2/90, 2%). DβH symmetric synapses on spines usually occurred on the spine neck. When DβH terminals formed junctions on spines, almost one-quarter (9/37 or 24%) of these spines received another synapse from an unlabeled terminal. Most of these second synapses were asymmetric (8/9 or 89%) and were formed on the spine head. Almost one-third of synapse-forming DβH terminals made asymmetric synapses (38/128 or 30%). The majority of asymmetric synapses occurred on spines (24/38, or 63%) (**Figures 3F and 5B**), though many were formed on dendrites (14/38 or 37%) (**Figures 3C and 5B**).

![**Electron micrographs show DβH-terminals in LA**. **(A)** A DβH -- terminal (DBH) apposes a dendritic spine (sp) and an unlabeled terminal (ut) forming an asymmetric synapse (asterisks) onto a spine (sp). **(B)** A DβH-terminal forms a symmetric synapse (arrows) with a dendrite (d). **(C)** A DβH-terminal forms a synapse (arrowheads) onto a dendrite (d) that also receives a synapse (arrows) from an unlabeled terminal (ut). Glial processes (g and asterisk) are also shown. **(D)** A DBH-terminal forms a symmetric synapse (arrows) onto a dendritic (d) whose spine (sp) receives a synapse (arrowheads) from an unlabeled terminal (ut). Also shown is a glial process (g). **(E)** A DβH-terminal is apposed to an unlabeled terminal (ut~1~) that forms a symmetric synapse (arrows) on a dendrite (d). An unlabeled terminal (ut~2~) forms an asymmetric synapse (arrowheads) on the dendrite\'s spine (sp). Unlabeled glial processes (g and \*) are also shown. **(F)** A DβH-terminal (DBH~1~) forms a synapse (arrows) onto a dendritic shaft (d~1~), whose spine (sp) receives an asymmetric synapse (arrowheads) from a second DβH-terminal (DBH~2~). DβH~2~ apposes unlabeled terminals (ut~1--2~) forming asymmetric synapses (arrowheads) with a spine (sp) and a dendrite (d~2~). Scale bars = 0.500 μm.](fnbeh-04-00162-g003){#F3}

![**DβH-profiles and glial processes immunoreactive for βAR 404 are associated with blood vessels**. **(A)** A DβH-axon (LAx) follows the contours of a blood vessel. The plasma membrane of the DβH-terminal (DβH) shows parallel alignment with the plasma membrane (small arrows) of an unlabeled terminal (ut). The basal lamina (asterisks) and an endothelial cell (End) separate the DβH-terminal from the blood vessel (BV). **(B)** A βAR 404-labeled glial process (LG) encircles a blood vessel (BV), which is bounded by an endothelial cell (end) and the basal lamina (asterisks). The βAR 404 astrocyte apposes unlabeled terminals (ut), one of which forms an asymmetric synapse (arrowheads) onto a dendritic spine (sp). Scale bars = 0.500 μm.](fnbeh-04-00162-g004){#F4}

![**Graphs show synaptic targets and specializations made by DβH terminals that form synapses**. **(A)** The vast majority of DBH symmetric synapses occurred on dendrites but a small proportion were made onto spines and somata. **(B)** Most DBH asymmetric synapses occurred on spines though some were formed on dendrites.](fnbeh-04-00162-g005){#F5}

βar immunoreactivity
--------------------

### βAR 248 is frequently localized to post-synaptic densities

By electron microscopy, βAR 248-ir was localized to neuronal perikarya, large and small dendritic shafts, dendritic spines, some axon terminals, and astrocytic processes (Figures [6](#F6){ref-type="fig"}A--C). Within dendritic shafts, reaction product rimmed the microtubules and the mitochondrial membranes, and in both shafts and spines was frequently concentrated along the plasma membranes and at post-synaptic densities (Figures [6](#F6){ref-type="fig"}A--C). βAR 248-ir axon terminals forming asymmetric synapses were occasionally observed (Figure [6](#F6){ref-type="fig"}B). βAR 248-ir was seen in perikarya with the morphological features of both inhibitory, e.g., invaginated nuclei and abundant cytoplasm, and excitatory cells, e.g., large nuclei and a thin rim of cytoplasm (Ribak and Seress, [@B70]; Farb et al., [@B28]). The subcellular distribution of βAR 248 immunoreactivity was consistent with previously published studies (Aoki, [@B4], [@B5]).

![**Both LA neurons and glia are immunoreactive (ir) for βAR**. **(A)** Unlabeled terminals (ut) form asymmetric synapses onto βAR 248-ir spines (LSp). The spinous portion (LSp) of a dendrite (d) is βAR 248-ir. **(B)** An unlabeled terminal (ut) synapses (arrowheads) onto a βAR 248-ir spine (LSp). βAR 248-labeled terminals (LT~1--2~) synapse (arrowheads) onto unlabeled spines (usp). **(C)** The βAR 248 reaction product in a dendrite (LD) is concentrated at the synapse (arrowheads) formed by an unlabeled terminal (ut) but also rims the microtubules (mt) and mitochondria (m). Also shown are a βAR 248-ir terminal (LT) and a small labeled dendrite (LD). **(D)** βAR 404-ir glial processes (LG, asterisks) are interposed between two unlabeled terminals (ut~1--2~). Also shown are an unlabeled terminal (ut~3~) synapsing (arrowheads) onto a βAR 404 ir spine (LSp) and a βAR 404-ir terminal (LT) synapsing (arrowheads) onto an unlabeled spine (usp). **(E)** A βAR 404-ir glial process (LG) surrounds a terminal (ut) that synapses (arrowheads) onto a spine (usp). Asterisks denote βAR 404-ir along the plasma membrane. **(F)** A βAR 404 ir glial process (LG, asterisks) surrounds an unlabeled terminal (ut) that forms an asymmetric synapse (arrowheads) onto a βAR 404-ir spine (LSp). Scale bars = 0.500 μm.](fnbeh-04-00162-g006){#F6}

### βAR 404 is predominantly localized to glial processes

Ultrastructural examination revealed that βAR 404 was predominantly localized to glial perikarya and processes but some neuronal processes were also immunoreactive (Figures [6](#F6){ref-type="fig"}D--F). Glial perikarya were distinguished from neuronal perikarya by the presence of filamentous organelles or glycogen granules whereas glial processes were recognized by their irregular contours and scarcity of organelles. When βAR 404 immunoreactivity occurred in large glial processes, the immunoperoxidase product rimmed the glial vesicles and mitochondria but was frequently concentrated along the plasma membranes (Figure [6](#F6){ref-type="fig"}E). Labeled glial processes frequently ensheathed or directly apposed unlabeled terminals forming asymmetric terminals (Figures [6](#F6){ref-type="fig"}D--F). Often, small labeled glial processes were interposed between unlabeled axon terminals (Figure [6](#F6){ref-type="fig"}D). Some axon terminals and dendritic shafts and spines were also immunoreactive for βAR 404 (Figures [6](#F6){ref-type="fig"}D,F). Large glial processes intensely immunoreactive for βAR 404 were sometimes apposed to the basal lamina and endothelial cells that bounded blood vessels (Figure [4](#F4){ref-type="fig"}B).

Discussion
==========

The present study used immunocytochemistry to identify and characterize: (1) terminals that contain norepinephrine, and (2) the cellular and subcellular distribution of βARs in the LA. The results show that most DβH terminals within the LA do not form synaptic junctions, but when they do, most synapses occur on dendritic shafts and a small proportion are formed on dendritic spines. While the majority of DβH synapses are symmetric, asymmetric synapses are also formed and most of these occur on spines. βARs are localized to both neurons and glial cells in the LA, and within neurons, βARs are localized to both excitatory and inhibitory cells and are frequently concentrated at the PSDs of dendritic shafts and spines. These results provide the morphological basis for understanding the role that NE and βARs play in modulating synaptic transmission within the LA.

Methodological considerations of βar antisera
---------------------------------------------

The βAR 404 antibody we used in this study was generated by using synthetic peptides directed against the amino acid sequences of hamster lung β~2~ARs (Dixon et al., [@B24]) but recognizes both the β~1~- and β~2~-subtypes (Strader et al., [@B77],[@B78]). This antibody has been extensively characterized using Western blot (Strader et al., [@B78]), immunoprecipitation of radiolabeled βAR (Strader et al., [@B77]) and preadsorption to the synthetic peptides using the exact correspondence to the antigens that were used to generate the antisera (Aoki, [@B5]). Immunolabeling with the antibody directed against the third intracellular loop, βAR 248, was consistent with previous studies, in which a monoclonal antibody directed the third intracellular loop was used (Aoki et al., [@B9]; Aoki, [@B5]). Though the results from several autoradiographic (Palacios and Kuhar, [@B63]; Minneman et al., [@B58]; Rainbow et al., [@B67]; Johnson et al., [@B45]) and *in situ* (Asanuma et al., [@B12]; Abraham et al., [@B1]) studies report different levels of β~1~- and β~2~-ARs across various brain regions, each of these studies demonstrated the presence of either β~1~- or β~2~-ARs in the amygdala complex and adjacent areas. Though the pattern of βAR immunolabeling we observe is homogenous compared to the distinct patterns reported in the autoradiographic and *in situ* studies, the antibodies we used likely recognize receptors in the perikaryal cytoplasm undergoing sequestration, desensitization, degradation or synthesis, as well as those that are ligand-binding (Strader et al., [@B77],[@B78]; Zemcik and Strader, [@B81]). Additionally, the antibodies we used recognize both the β~1~- and the β~2~-subunits, though they were directed against the β~2~ subunit, and recognize a greater population of cells, compared to those identified by *in situ*. It is thus not unexpected that the distribution of βARs identified by immunolabeling differs from patterns seen by other methods.

Synaptic characterization of dβh within the la
----------------------------------------------

Our results show that most DβH terminals within single planes of section do not form synapses but instead form non-junctional appositions with dendrites or unlabeled terminals. Though these findings are consistent with previous studies showing the non-junctional nature of DβH terminals in the amygdala (Asan, [@B10], [@B11]) and other brain regions (Descarries et al., [@B23]; Seguela et al., [@B74]; Aoki et al., [@B8]), it is likely that we underestimated the degree to which DβH terminals form synapses. Several factors might account for our failure to detect these synapses: the use of detergent to permeabilize membranes and improve penetration of the DβH antibody, dense DAB reaction product that obscures the morphological features of labeled terminals, and the thin, small size of synapses that may be overlooked without serial section examination. Though we followed some non-junctional DβH terminals for 2--5 sections, this series was too small to establish whether these DβH terminals ultimately formed synapses. Our results, showing that approximately 30% of DβH terminals in the LA form synaptic junctions, is higher than what has been reported for the BLA (Asan, [@B11]) and may represent regional differences within the amygdala complex or methodological differences attributable to our use of a stronger fixative that results in better preservation of membrane ultrastructure, enabling detection of a greater number of synapses. Our study showing that DβH terminals form both symmetric and asymmetric synapses, is consistent with previous studies done in basal amygdala (Asan, [@B11]; Li et al., [@B52]) and other brain regions (Seguela et al., [@B74]; Aoki et al., [@B8]). Though Li et al. ([@B53]) reported that the proportion of symmetric and asymmetric synapses was almost equivalent in the BLA, our results showing that DβH terminals form approximately twice as many symmetric synapses than asymmetric synapses, are similar to what Asan ([@B11]) found in BLA. Though asymmetric junctions have been correlated with glutamatergic transmission and symmetric synapses with GABAergic transmission (Peters et al., [@B64]), the distinction in catecholaminergic systems is less clear and may instead reflect the target dendrite and the synaptic machinery present on that target. For example, though DβH terminals were more likely to form symmetric rather than asymmetric synapses in LA, most asymmetric synapses were formed on dendritic spines, which receive most of the glutamatergic synapses in the LA (Farb et al., [@B27]). Though serial section analysis shows that just 7% of dendritic spines in LA receive more than one synapse, and only 2% of LA spines receive both an asymmetric and a symmetric synapse (Ostroff et al., [@B62]), we found that when DβH terminals synapse on spines, approximately 25% of these spines also receive synapses from other unlabeled terminals and most of these junctions are asymmetric. This observation and the prevalence of βAR labeling at the PSDs of asymmetric synapses in dendritic spines suggest that NE may modulate glutamatergic transmission at LA spines. These results are consistent with electrophysiological findings showing that NE modulates glutamatergic neurotransmission in amygdala (Huang et al., [@B42], [@B40],[@B41]) and activation of βARs enhances synaptic transmission in amygdala (Gean et al., [@B32]; Huang et al., [@B40],[@B41]), hippocampus (Raman et al., [@B68]), and prefrontal cortex (Ji et al., [@B44]). Preliminary data from our lab indicate that LA dendritic spines and shafts that are immunoreactive for βARs receive synaptic contacts from axon terminals originating either from the acoustic thalamus or cortex (unpublished observations), pathways known to be glutamatergic (Farb et al., [@B27]; Farb and LeDoux, [@B29], [@B30]). Thus, NE may modulate synaptic transmission of these sensory pathways to the LA either by its convergence onto the same dendritic shafts and spines as cortical or thalamic axons or via activation of βARs on these dendritic processes.

βars are present in both excitatory and inhibitory cells in the la
------------------------------------------------------------------

Our confocal and EM findings, showing that the neuronal form of the βAR is localized to both excitatory and inhibitory LA cells, are consistent with anatomical and pharmacological studies showing that βARs are present on pyramidal and GABAergic cells in hippocampus (Milner et al., [@B57]; Hillman et al., [@B37]; Cox et al., [@B21]). Within amygdala, *in vitro* electrophysiological studies have shown that the activation of βARs on pyramidal cells results in enhancement of excitatory transmission by NE whereas blockade of βARs by propranolol reduces excitatory transmission (Gean et al., [@B32]; Huang et al., [@B39], [@B42]; Ferry et al., [@B31]; Buffalari and Grace, [@B18]) and blocks late LTP (Johnson et al., [@B46]) on these cells. While anatomical and *in vitro*studies within the amygdala have shown a relationship between NE and GABA, they have yet to demonstrate whether this association is attributable to the activation of βARs on GABA cells in the LA. For example, GABAergic cells in BLA receive synaptic contacts from DβH terminals (Li et al., [@B52]), indicating that NE may directly modulate GABAergic transmission. Additionally, application of NE in LA slices, suppresses feed-forward GABAergic inhibition of projection neurons (Tully et al., [@B80]). *In vivo,*when the βAR antagonist propranolol is administered i.p., the memory-enhancing effects of the GABA~A~ antagonist bicuculline are blocked, while clenbuterol, the βAR agonist, blocks the memory-impairing effects of the GABA~A~ agonist muscimol (Introini-Collison et al., [@B43]). Our data showing that βARs are present on GABA cells in the LA provides a framework for understanding these physiological and behavioral findings.

βars at non-synaptic sites
--------------------------

The large proportion of non-junctional appositions formed by DβH terminals in amygdala may reflect NE release via volume transmission (Descarries et al., [@B23]; Agnati et al., [@B2]) or non-synaptic mechanisms. Consistent with these ideas are dual-label ultrastructural studies in cortex and hippocampus showing that dendrites that are immunoreactive for βAR were near catecholaminergic axons but rarely in direct contact with them, though astrocytic processes were (Aoki et al., [@B9]; Aoki, [@B4]; Aoki and Pickel, [@B7]; Milner et al., [@B57]). Our findings, showing extensive βAR immunoreactivity of glial processes, support the idea that NE might act indirectly through astrocytic processes and are consistent with previous ultrastructural studies (Aoki et al., [@B6], Aoki [@B4], [@B5]; Milner et al., [@B57]) and *in vivo* and *in vitro* binding studies from various brain areas showing βARs expression or binding in astrocytes (Burgess and McCarthy, [@B19]; Lerea and McCarthy, [@B51]; Stone and John, [@B76]). Activation of astrocytic βARs may modulate glutamatergic transmission at excitatory synapses via close appositions or glial ensheathment of these synapses (Shao and McCarthy, [@B75]). Additionally, astrocytic βARs may modulate gap junction permeability, release glucose for energy metabolism, or play a role in cytoskeletal rearrangements that accompany neuronal plasticity (for reviews, see Gibbs et al., [@B34]; Giaume et al., [@B33]).

Conclusions
===========

Together, results from this study suggest that norepinephrine-containing terminals in the LA may engage in non-synaptic transmission in the LA. The presence of β~2~ARs in both excitatory and inhibitory neurons suggests that NE has a prolific role in the modulation of synaptic transmission in LA. Further, the prevalence of βARs in glial cells adds a further dimension to the role of NE in modulating synaptic transmission in LA since glial cells may play a role in regulating excitatory transmission. These data provide an anatomical foundation for interpretation of physiological and behavioral studies of the role of NE in the amygdala.
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